OxVax Company

OxVax focused on the development of an advanced next-generation dendritic cell vaccine platform for the treatment of solid tumor cancers.

Funding Status: Seed
Headquarters: Oxford, Oxfordshire, United Kingdom
Last Funding Date: 2021-04-21
Investors Number: 2
Founded Date: 2021-01-01
Industry: Dendritic Cells
Last Funding Type: Seed